Literature DB >> 6933524

Inhibition of Ca2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins.

D Y Hui, J A Harmony.   

Abstract

Low density lipoproteins (LDL) in which apoB is the only protein constituent inhibit lymphocyte activation induced by the mitogen phytohemagglutinin. LDL suppress primary induction events, most notably enhanced Ca2+ accumulation, which occur as a result of mitogen-triggered alterations of the lymphocyte plasma membrane. Receptors in the lymphocyte membrane--designated "immunoregulatory receptors"--recognize and bind apoB-LDL. Under conditions of receptor saturation, about 22,500 +/- 4500 LDL particles are bound to the lymphocyte surface at 4 and 37 degrees C. The dissociation constant, Kd, is 1.76 X 10(-7) M and is also independent of temperature. Suppression of phytohemagglutinin-induced 45Ca2+ accumulation by LDL is a receptor-dependent process: inhibition is contingent on attachment of LDL to the immunoregulatory receptors. This conclusion is supported by three lines of evidence. First, heparin restores the susceptibility of the lymphocytes to mitogenic challenge by displacing membrane-bound LDL. Second, the immnoregulatory potency of LDL correlates directly with the amount of LDL bound at the cell surface. Third, LDL-Sepharose complexes, which cannot be internalized by the cells, are as immunosuppressive as soluble LDL. This demonstrates that membrane-bound plasma lipoproteins influence the behavior of intact cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933524      PMCID: PMC349927          DOI: 10.1073/pnas.77.8.4764

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody.

Authors:  H F Hoff; R L Jackson; S J Mao; A M Gotto
Journal:  Biochim Biophys Acta       Date:  1974-06-07

2.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

3.  Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper- -lipoproteinemia. Demonstration of macromolecular heterogeneity.

Authors:  W R Fisher; M G Hammond; G L Warmke
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

4.  [Enzymatic determination of total cholesterol in serum (author's transl)].

Authors:  P Röschlau; E Bernt; W Gruber
Journal:  Z Klin Chem Klin Biochem       Date:  1974-09

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  [On the enzymatic method of neutral fat determination in biological matter].

Authors:  F H Schmidt; K von Dahl
Journal:  Z Klin Chem Klin Biochem       Date:  1968-05

7.  The structure of human density lipoprotein: a study of the effect of phospholipase A and trypsin on its components and of the behavior of the lipid and protein moieties at the air-water interphase.

Authors:  G Camejo
Journal:  Biochim Biophys Acta       Date:  1969-03

8.  Isolation of pure human peripheral blood T-lymphocytes using nylon wool columns.

Authors:  S A Eisen; H J Wedner; C W Parker
Journal:  Immunol Commun       Date:  1972

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  Visualization of concanavalin A-binding sites with scanning electron microscopy.

Authors:  N K Weller
Journal:  J Cell Biol       Date:  1974-11       Impact factor: 10.539

View more
  4 in total

Review 1.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

2.  Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patients.

Authors:  P V Subbaiah; J T Ogilvie
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

3.  Modulation of human lymphocyte responses by low density lipoproteins (LDL): enhancement but not immunosuppression is mediated by LDL receptors.

Authors:  J A Cuthbert; P E Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.